Table 3.
Assay | After 1st Vaccine * | After 2nd Vaccine ** |
---|---|---|
Days for Anti-RBD–IgG; mean ± SD (range) | 11.7 ± 3.6 (7–21) | 13.7 ± 5.6 days (7–38) |
Anti-RBD-IgG (Geometric mean (CI95%)) | 0.11 (0.08–0.14) | 32.55 (31.11–34.05) |
Days for neutralizing Ab; Mean ± SD (range) | 14.1 ± 0.4 (13–17) | 6.9 ± 0.6 (4–10) |
Neutralizing Ab (Geometric mean (CI95%)) | 23.41 (17.95–30.54) | 745 (611.5–908.9) |
* N = 227 participants for anti-RBD-IgG and 71 participants for neutralizing Ab. ** N = 823 participants for anti-RBD-IgG and 185 participants for neutralizing Ab.